JAMA Surgery : Voucher-Based Kidney Donation and Redemption for Future Transplant
Interview with Jeff L. Veale, MD, author of Voucher-Based Kidney Donation and Redemption for Future Transplant (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - June 23, 2021 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
Mycophenolate vs Methotrexate for Uveitis, Home-Based Physical Therapy After Hip Fracture, Dialysis Facility Ownership Profit Status and Kidney Transplantation, and more
September 10, 2019 edition of the weekly JAMA Editors' Summary (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - September 10, 2019 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Patient Enrollment for Phase 2 ONC201 Karnofsky Performance 60 and Good Kidney and Liver Performance
Peter Anderson, MD, Pediatric Hematology Oncology and Blood and Marrow Transplantation of Cleveland Clinic discusses the the Patient Enrollment for Phase 2 ONC201 and the requirements such as Karnofsk...
Author: Cancer-News
Added: 01/24/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 25, 2018 Category: Cancer & Oncology Source Type: podcasts
Comparison of Transcatheter Aortic Valves, Infant Formula and Type 1 Diabetes, Racial Disparities in Live Donor Kidney Transplantation, and more
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the January 02, 2018 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - January 2, 2018 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients
When a patient receives a kidney transplant, there is a possibility that their body will reject this new organ and a variety of treatments are used to try to prevent this. However, these treatments can cause their own unwanted side effects. In a new Cochrane Review in July 2017, Krishna Karpe and colleagues from Canberra Hospital in Australia looked at the evidence for alleviating this for the group of drugs known as Calcineurin inhibitors. Here ’s Krishna to tell us what they found. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - December 14, 2017 Category: General Medicine Authors: Cochrane Source Type: podcasts
PodMed – Week of August 7, 2017
This week’s topics include antibody depletion for kidney transplantation, a way to reverse dabigatran, the costs of board certification, and opioid use in the US population. Program notes: 0:43 Fees for medical specialty board 1:45 Over $3000 2:46 Kidney transplantation and reducing antibodies 3:45 Enzyme to deplete 4:50 Enzyme cleaves all four classes of IgG […] (Source: Johns Hopkins Medicine Weekly Health News)
Source: Johns Hopkins Medicine Weekly Health News - August 4, 2017 Category: Consumer Health News Authors: Elizabeth Tracey Johns Hopkins Medicine Tags: Alcohol And Drug Abuse All Podcasts Critical care medicine Kidney And Urinary Disorders Pain And Pain Relief PodMed Transplant Urology Source Type: podcasts
Renal Medicine Series: The Lancet: May 25, 2017
Danilo Fliser discusses a clinical Series that examines acute kidney injury, and priorities for graft preservation after renal transplantation. (Source: Listen to The Lancet)
Source: Listen to The Lancet - May 26, 2017 Category: General Medicine Authors: The Lancet Source Type: podcasts
Immunosuppressive agents for treating IgA nephropathy
IgA nephropathy is a kidney condition, leading to kidney failure for many of those who are affected. About 10-20% of patients require dialysis or a kidney transplant within 10 years, and 30-40% within 20 years, from their disease onset. This long time between diagnosis and kidney failure makes it difficult to establish the most effective and safest treatment. In August 2015, Marinella Ruospo and her colleagues from Bari, Italy updated their Cochrane Review of immunosuppressive therapies and she tells us what they have found in this Evidence pod. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - February 2, 2017 Category: Journals (General) Authors: Cochrane Source Type: podcasts
Immunosuppressive agents for treating IgA nephropathy
IgA nephropathy is a kidney condition, leading to kidney failure for many of those who are affected. About 10-20% of patients require dialysis or a kidney transplant within 10 years, and 30-40% within 20 years, from their disease onset. This long time between diagnosis and kidney failure makes it difficult to establish the most effective and safest treatment. In August 2015, Marinella Ruospo and her colleagues from Bari, Italy updated their Cochrane Review of immunosuppressive therapies and she tells us what they have found in this podcast. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - February 2, 2017 Category: General Medicine Authors: Cochrane Source Type: podcasts
How Does Dialysis Care Differ for Minority Patients?
A large study found that patients from racial minority groups were less likely to receive certain types of dialysis or to receive kidney transplants. (Source: Medscape Nephrology Podcast)
Source: Medscape Nephrology Podcast - February 2, 2016 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts
